These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 3039217)

  • 1. Down-regulation of central serotonin S2 receptors after repeated treatment with quinupramine in rats.
    Sakamoto H; Yokoyama N; Nishimoto T; Murai K; Tatsumi H; Kohno S; Ohata K
    Jpn J Pharmacol; 1987 Apr; 43(4):369-77. PubMed ID: 3039217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of quinupramine on the central monoamine uptake systems and involvement of pharmacokinetics in its pharmacological activities.
    Sakamoto H; Yokoyama N; Nishimoto T; Murai K; Tatsumi H; Kohno S; Ohata K
    Jpn J Pharmacol; 1987 Oct; 45(2):169-75. PubMed ID: 3437586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of tricyclic antidepressant drugs on receptor binding sites and Ca2+ binding to sarcoplasmic reticulum in rat heart].
    Sakamoto H; Yokoyama N; Nishimoto T; Kohno S; Ohata K; Murai K; Tatsumi H
    Nihon Yakurigaku Zasshi; 1989 Oct; 94(4):229-36. PubMed ID: 2613103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding characteristics of [3H]quinupramine to rat brain membrane fractions.
    Sakamoto H; Yokoyama N; Nishimoto T; Murai K; Tatsumi H; Kohno S; Ohata K
    Jpn J Pharmacol; 1987 Sep; 45(1):27-36. PubMed ID: 2824895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Behavioral effects of quinupramine, a new tricyclic antidepressant].
    Ueki S; Yamamoto T; Shimazoe T; Shibata S; Tani Y; Machida K; Hojo M; Yoshida Y; Tatsumi H
    Nihon Yakurigaku Zasshi; 1988 Jun; 91(6):359-69. PubMed ID: 3417209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Electroencephalographic effect of quinupramine in the rabbit].
    Watanabe S; Ohta H; Yamashita K; Ohno M; Tani Y; Furuya Y; Ueki S
    Nihon Yakurigaku Zasshi; 1987 Jun; 89(6):339-54. PubMed ID: 3623335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bupropion: a new antidepressant drug, the mechanism of action of which is not associated with down-regulation of postsynaptic beta-adrenergic, serotonergic (5-HT2), alpha 2-adrenergic, imipramine and dopaminergic receptors in brain.
    Ferris RM; Beaman OJ
    Neuropharmacology; 1983 Nov; 22(11):1257-67. PubMed ID: 6320035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Receptor binding profile of quinupramine, a new tricyclic antidepressant.
    Sakamoto H; Yokoyama N; Kohno S; Ohata K
    Jpn J Pharmacol; 1984 Dec; 36(4):455-60. PubMed ID: 6098759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of iprindole, imipramine and mianserin action on brain serotonergic and beta adrenergic receptors.
    Gandolfi O; Barbaccia ML; Costa E
    J Pharmacol Exp Ther; 1984 Jun; 229(3):782-6. PubMed ID: 6327970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of antidepressant treatment on brain monoaminergic receptors.
    Maggi A; U'Prichard DC; Enna SJ
    Eur J Pharmacol; 1980 Jan; 61(2):91-8. PubMed ID: 6101555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of imipramine and serotonin-2 agonists and antagonists on serotonin-2 and beta-adrenergic receptors following noradrenergic or serotonergic denervation.
    Eison AS; Eison MS; Yocca FD; Gianutsos G
    Life Sci; 1989; 44(19):1419-27. PubMed ID: 2785627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regionally specific neural adaptation of beta adrenergic and 5-hydroxytryptamine2 receptors after antidepressant administration in the forced swim test and after chronic antidepressant drug treatment.
    Paul IA; Duncan GE; Powell KR; Mueller RA; Hong JS; Breese GR
    J Pharmacol Exp Ther; 1988 Sep; 246(3):956-62. PubMed ID: 2843636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Noradrenergic and serotonergic input necessary for imipramine-induced changes in beta but not S2 receptor densities.
    Dumbrille-Ross A; Tang SW
    Psychiatry Res; 1983 Jul; 9(3):207-15. PubMed ID: 6312480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of chronic treatment with tricyclic antidepressant drugs on identified brain noradrenergic and serotonergic neurons.
    Svensson TH
    Acta Psychiatr Scand Suppl; 1980; 280():121-31. PubMed ID: 6250320
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of prolonged administration of milnacipran, a new antidepressant, on receptors and monoamine uptake in the brain of the rat.
    Assie MB; Charveron M; Palmier C; Puozzo C; Moret C; Briley M
    Neuropharmacology; 1992 Feb; 31(2):149-55. PubMed ID: 1313158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imipramine alters beta-adrenergic, but not serotonergic, mediated responses in rat hippocampal pyramidal cells.
    Beck SG; Halloran PM
    Brain Res; 1989 Dec; 504(1):72-81. PubMed ID: 2557127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conformationally restricted tricyclic antidepressants. 1. Octahydrodibenzazepinonaphthyridines as rigid imipramine analogues.
    Martin AR; Paradkar VM; Peng GW; Speth RC; Yamamura HI; Horn AS
    J Med Chem; 1980 Aug; 23(8):865-73. PubMed ID: 6249933
    [No Abstract]   [Full Text] [Related]  

  • 18. Reevaluation of the regulation of beta-adrenergic receptor binding by desipramine treatment.
    Riva MA; Creese I
    Mol Pharmacol; 1989 Jul; 36(1):211-8. PubMed ID: 2546051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabotropic glutamate receptors and neuroadaptation to antidepressants: imipramine-induced down-regulation of beta-adrenergic receptors in mice treated with metabotropic glutamate 2/3 receptor ligands.
    Matrisciano F; Scaccianoce S; Del Bianco P; Panaccione I; Canudas AM; Battaglia G; Riozzi B; Ngomba RT; Molinaro G; Tatarelli R; Melchiorri D; Nicoletti F
    J Neurochem; 2005 Jun; 93(5):1345-52. PubMed ID: 15934953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding of [3H]imipramine and [3H]desipramine as biochemical tools for studies in depression.
    Langer SZ; Raisman R
    Neuropharmacology; 1983 Mar; 22(3 Spec No):407-13. PubMed ID: 6304558
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.